<DOC>
	<DOCNO>NCT02638935</DOCNO>
	<brief_summary>The primary aim study evaluate VTIQ addition BI-RADS® categorization improve diagnostic accuracy respect detection malignancy , particular BI-RADS® category 3 4a . The idea study restage patient categories 3 4a accord predefined VTIQ cut-off value 3.5 m/s ( 37 kPa ) .</brief_summary>
	<brief_title>Evaluation Virtual Touch Tissue Imaging Quantification ( VTIQ - 2D-SWE ) Assessment BI-RADS® 3 4 Lesions</brief_title>
	<detailed_description>Elastography method image tissue stiffness . It base shear wave velocity information map create image stiffness region interest . Sonoelastography use differentiate benign malignant lesion since malignant lesion alter tissue elasticity . Adding Shear Wave elastographic feature BI-RADS® feature analysis- especially lesion score BI-RADS® 3 4a- improve specificity breast US mass assessment without loss sensitivity . The BI-RADS® category define risk malignant lesion vary benign BI-RADS® 2 lesion , 2 % malignancy rate BI-RADS® 3 2- 95 % BI-RADS® 4 ( 4a 2-10 % ; 4b 10-50 % ; 4c 50-95 % ) . Based probability , biopsy recommend BI-RADS® 4 5 lesion short-term follow-up examination BI-RADS® 3 . Consequently , 2 % Ultrasound visible breast cancer directly detect put BI-RADS® 3 category . In contrast , BI-RADS® 4a category 90 % biopsy unnecessary . The main aim confirmatory study use Virtual Touch Tissue Imaging Quantification order reduce unnecessary benign biopsy without reduction number detect cancer . This multi-center study involve 11 site 6 country . Anticipated study start December 2015 . Recruitment take place course patient 's routine visit certify breast unit . All study participant receive VTIQ addition standard ultrasound . The standard BI-RADS® Ultrasound ( US ) category ( BI-RADS® 3-4c ) VTIQ value correlate histological result . Additionally , local ( BI-RADS® give site ) central expert BI-RADS® assessment compare ( BI-RADS® assessment assessment variable lead BI-RADS® value separately ) ass inter-rater reliability . In addition , BI-RADS® assessment compare histological results.Enrollment goal total 1000 case , split group minimum 300 BI-RADS® 3 , 400 BI-RADS® 4a , 100 BI-RADS® 4b , 100 BI-RADS® 4c . Monitoring performed Coordination Center Clinical Trials ( KKS Heidelberg ) . Completeness , validity plausibility data check time data entry ( edit-checks ) use validate program , generate query . The investigator designate representative oblige clarify explain query . If correction make database close used statistical analysis . All data management procedure carry validated system accord current Standard Operating Procedures ( SOPs ) Institute Medical Biometry Informatics .</detailed_description>
	<mesh_term>Breast Neoplasms</mesh_term>
	<criteria>Female Age ≥18 year Patients lesion &gt; 0.5 cm large diameter size , initially score BIRADS® 3 , 4a , 4b 4c Bmode ultrasound Informed consent histological examination ( core cut biopsy ( CCB ) , vacuumassisted biopsy ( VAB ) , fine needle aspiration ( FNA ) surgery ) already give course clinical routine Signed informed consent study participation Pregnant lactate woman Women breast implant side lesion Women underwent local radiation chemotherapy within last 12 month Women history breast cancer breast surgery quadrant Lesions close scar tissue ( &lt; 1cm ) Skin lesion lesion biopsied previously Lesion large 4 cm long dimension No lesion include 50 % lesion 4 cm beneath skin level .</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2016</verification_date>
	<keyword>Virtual Touch Tissue Imaging</keyword>
	<keyword>VTIQ</keyword>
	<keyword>Elastography</keyword>
	<keyword>Breast Cancer</keyword>
	<keyword>BI-RADS</keyword>
	<keyword>Differentiation breast lesion</keyword>
	<keyword>Breast Lesion</keyword>
</DOC>